title: [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
abstract: The (18)F-choline PET-CT (FCH) has better performance in the assessment of patients with prostate cancer than (18)F-FDG. However, similarly, it is also not a tumor specific radiotracer. We present four (18)F-FCH PET-CT scans in which false positive findings were correctly assessed after evaluation with CT, clinical parameters and/or histological analysis.
authors.affiliation: Servicio de Medicina Nuclear, Hospital General Universitario de Ciudad Real, Ciudad Real, España. angarvice@yahoo.es
authors.forename: A M
authors.initials: AM
authors.lastname: García Vicente
authors.forename: A
authors.initials: A
authors.lastname: Núñez García
authors.forename: A M
authors.initials: AM
authors.lastname: Soriano Castrejón
authors.forename: G A
authors.initials: GA
authors.lastname: Jiménez Londoño
authors.forename: J M
authors.initials: JM
authors.lastname: Cordero García
authors.forename: A
authors.initials: A
authors.lastname: Palomar Muñoz
mesh_terms: D002794:Choline / Q000031:analogs & derivatives*; D005189:False Positive Reactions; D005462:Fluorine Radioisotopes; D006801:Humans; D008297:Male; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography / Q000379:methods*; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D005462:Fluorine Radioisotopes; C516370:fluoromethylcholine; D002794:Choline